These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 15101043)

  • 1. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
    Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
    Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features.
    Christacos NC; Quade BJ; Dal Cin P; Morton CC
    Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
    Quade BJ
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential gene expression in leiomyosarcoma.
    Skubitz KM; Skubitz AP
    Cancer; 2003 Sep; 98(5):1029-38. PubMed ID: 12942572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
    Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
    Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of human adenomyosis.
    Hever A; Roth RB; Hevezi PA; Lee J; Willhite D; White EC; Marin EM; Herrera R; Acosta HM; Acosta AJ; Zlotnik A
    Mol Hum Reprod; 2006 Dec; 12(12):737-48. PubMed ID: 17020905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
    Fletcher JA; Morton CC; Pavelka K; Lage JM
    Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
    Jeffers MD; Richmond JA; Macaulay EM
    Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray study of gene expression in uterine leiomyoma.
    Litovkin KV; Ivanova OV; Bauer A; Hoheisel JD; Bubnov VV; Zaporozhan VN
    Exp Oncol; 2008 Jun; 30(2):106-11. PubMed ID: 18566572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic considerations of uterine smooth muscle tumors.
    Prayson RA; Hart WR
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor gene expression in human smooth muscle tumors.
    Gloudemans T; Prinsen I; Van Unnik JA; Lips CJ; Den Otter W; Sussenbach JS
    Cancer Res; 1990 Oct; 50(20):6689-95. PubMed ID: 2208134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
    de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
    Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXO3a deregulation in uterine smooth muscle tumors.
    de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
    Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression in uterine leiomyoma.
    Skubitz KM; Skubitz AP
    J Lab Clin Med; 2003 May; 141(5):297-308. PubMed ID: 12761473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.
    Adams CL; Dimitrova I; Post MD; Gibson L; Spillman MA; Behbakht K; Bradford AP
    Exp Mol Pathol; 2019 Oct; 110():104284. PubMed ID: 31301306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from pregnancy and parturition: uterine leiomyomas result from discordant differentiation and dedifferentiation responses in smooth muscle cells.
    Cesen-Cummings K; Walker CL; Davis BJ
    Med Hypotheses; 2000 Dec; 55(6):485-90. PubMed ID: 11090295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.